Gain-of-Function of Stat5 Leads to Excessive Granulopoiesis and Lethal Extravasation of Granulocytes to the Lung

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Lin, Wan Chi ^a   Schmidt, Jeffrey W ^a   Creamer, Bradley A ^a,c   Triplett, Aleata A ^a   Wagner, Kay Uwe ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c MISSOURI SOUTHERN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STAT5 PROTEIN;

AIRWAY OBSTRUCTION; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL GROWTH; CELL LINEAGE; CELL SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; GAIN OF FUNCTION MUTATION; GRANULOCYTE; GRANULOPOIESIS; LEUKOCYTE MIGRATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; WILD TYPE;

ALLELES; ANIMALS; GRANULOCYTES; HEMATOPOIESIS; LUNG; MICE; MICE, TRANSGENIC; STAT5 TRANSCRIPTION FACTOR;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 84875669829     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060902     Document Type: Article

References (55)

1. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, et al. (1997) Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 11: 179-186.
2. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, et al. (1997) Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A 94: 7239-7244.
3. Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, et al. (1998) Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93: 841-850.
4. Socolovsky M, Fallon AE, Wang S, Brugnara C, Lodish HF, (1999) Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 98: 181-191.
5. Moriggl R, Topham DJ, Teglund S, Sexl V, McKay C, et al. (1999) Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10: 249-259.
6. Cui Y, Riedlinger G, Miyoshi K, Tang W, Li C, et al. (2004) Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol Cell Biol 24: 8037-8047.
7. Li G, Wang Z, Zhang Y, Kang Z, Haviernikova E, et al. (2007) STAT5 requires the N-domain to maintain hematopoietic stem cell repopulating function and appropriate lymphoid-myeloid lineage output. Exp Hematol 35: 1684-1694. S0301-472X(07)00535-8 [pii];10.1016/j.exphem.2007.08.026 [doi].
8. Kimura A, Martin C, Robinson GW, Simone JM, Chen W, et al. (2010) The gene encoding the hematopoietic stem cell regulator CCN3/NOV is under direct cytokine control through the transcription factors STAT5A/B. J Biol Chem. 28532704-.32709 M110.141804 [pii];10.1074/jbc.M110.141804 [doi].
9. Yao Z, Cui Y, Watford WT, Bream JH, Yamaoka K, et al. (2006) Stat5a/b are essential for normal lymphoid development and differentiation. Proc Natl Acad Sci U S A 1031000-1005. 0507350103 [pii];10.1073/pnas.0507350103 [doi].
10. Hoelbl A, Kovacic B, Kerenyi MA, Simma O, Warsch W, et al. (2006) Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. Blood 1074898-4906. 2005-09-3596 [pii];10.1182/blood-2005-09-3596 [doi].
11. Dai X, Chen Y, Di L, Podd A, Li G, et al. (2007) Stat5 is essential for early B cell development but not for B cell maturation and function. J Immunol 179: 1068-1079 179/2/1068 [pii].
12. Kimura A, Rieger MA, Simone JM, Chen W, Wickre MC, et al. (2009) The transcription factors STAT5A/B regulate GM-CSF-mediated granulopoiesis. Blood 1144721-4728.blood-2009-04-216390 [pii];10.1182/blood-2009-04-216390 [doi].
13. Kieslinger M, Woldman I, Moriggl R, Hofmann J, Marine JC, et al. (2000) Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation. Genes Dev 14: 232-244.
14. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, et al. (2003) Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 349: 1139-1147.
15. Hwa V, Little B, Adiyaman P, Kofoed EM, Pratt KL, et al. (2005) Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b. J Clin Endocrinol Metab 90: 4260-4266 jc.2005-0515 [pii];10.1210/jc.2005-0515 [doi].
16. Bernasconi A, Marino R, Ribas A, Rossi J, Ciaccio M, et al. (2006) Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation. Pediatrics 118: e1584-e1592 peds.2005-2882 [pii];10.1542/peds.2005-2882 [doi].
17. Nadeau K, Hwa V, Rosenfeld RG, (2011) STAT5b deficiency: an unsuspected cause of growth failure, immunodeficiency, and severe pulmonary disease. J Pediatr 158: 701-708 S0022-3476(10)01154-6 [pii];10.1016/j.jpeds.2010.12.042 [doi].
18. Schmidt JW, Wagner KU (2012) Activation of Janus Kinases during Tumorigenesis. Chapter 15259-288.
19. Valentino L, Pierre J, (2006) JAK/STAT signal transduction: regulators and implication in hematological malignancies. Biochem Pharmacol 71: 713-721.
20. Ghoreschi K, Laurence A, O'Shea JJ, (2009) Janus kinases in immune cell signaling. Immunol Rev 228: 273-287.
21. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, et al. (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365: 1054-1061 S0140-6736(05)71142-9 [pii];10.1016/S0140-6736(05)71142-9 [doi].
22. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, et al. (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434: 1144-1148 nature03546 [pii];10.1038/nature03546 [doi].
23. Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, et al. (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7: 387-397 S1535-6108(05)00094-2 [pii];10.1016/j.ccr.2005.03.023 [doi].
24. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, et al. (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352: 1779-1790 352/17/1779 [pii];10.1056/NEJMoa051113 [doi].
25. Buettner R, Mora LB, Jove R, (2002) Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8: 945-954.
26. Brizzi MF, Dentelli P, Rosso A, Yarden Y, Pegoraro L, (1999) STAT protein recruitment and activation in c-Kit deletion mutants. J Biol Chem 274: 16965-16972.
27. Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, et al. (2003) Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations. Blood 101: 3164-3173 10.1182/blood-2002-06-1677 [doi];2002-06-1677 [pii].
28. Taketani T, Taki T, Sugita K, Furuichi Y, Ishii E, et al. (2004) FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy. Blood 103: 1085-1088 10.1182/blood-2003-02-0418 [doi];2003-02-0418 [pii].
29. Moriggl R, Sexl V, Kenner L, Duntsch C, Stangl K, et al. (2005) Stat5 tetramer formation is associated with leukemogenesis. Cancer Cell 7: 87-99.
30. Joliot V, Cormier F, Medyouf H, Alcalde H, Ghysdael J, (2006) Constitutive STAT5 activation specifically cooperates with the loss of p53 function in B-cell lymphomagenesis. Oncogene 25: 4573-4584 1209480 [pii];10.1038/sj.onc.1209480 [doi].
31. Hennighausen L, Wall RJ, Tillmann U, Li M, Furth PA, (1995) Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV-LTR and the tetracycline responsive system. J Cell Biochem 59: 463-472.
32. Huettner CS, Zhang P, Van Etten RA, Tenen DG, (2000) Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat Genet 24: 57-60.
33. Letai A, Sorcinelli MD, Beard C, Korsmeyer SJ, (2004) Antiapoptotic BCL-2 is required for maintenance of a model leukemia. Cancer Cell 6: 241-249.
34. Refaeli Y, Young RM, Turner BC, Duda J, Field KA, et al. (2008) The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas. PLoS Biol 6: e152.
35. Tiedt R, Hao-Shen H, Sobas MA, Looser R, Dirnhofer S, et al. (2008) Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice. Blood 111: 3931-3940.
36. Li J, Spensberger D, Ahn JS, Anand S, Beer PA, et al. (2010) JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia. Blood 116: 1528-1538.
37. Fievez L, Desmet C, Henry E, Pajak B, Hegenbarth S, et al. (2007) STAT5 is an ambivalent regulator of neutrophil homeostasis. PLoS One 2: e727.
38. Matsumura I, Kitamura T, Wakao H, Tanaka H, Hashimoto K, et al. (1999) Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J 18: 1367-1377.
39. Wang Z, Li G, Tse W, Bunting KD, (2009) Conditional deletion of STAT5 in adult mouse hematopoietic stem cells causes loss of quiescence and permits efficient nonablative stem cell replacement. Blood 113: 4856-4865 blood-2008-09-181107 [pii];10.1182/blood-2008-09-181107 [doi].
40. Felsher DW, Bishop JM, (1999) Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 4: 199-207.
41. Koschmieder S, Gottgens B, Zhang P, Iwasaki-Arai J, Akashi K, et al. (2005) Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. Blood 105: 324-334 10.1182/blood-2003-12-4369 [doi];2003-12-4369 [pii].
42. Iavnilovitch E, Groner B, Barash I, (2002) Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis. Mol Cancer Res 1: 32-47.
43. Iavnilovitch E, Cardiff RD, Groner B, Barash I, (2004) Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice. Int J Cancer 112: 607-619.
44. Wagner KU, Rui H, (2008) Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression. J Mammary Gland Biol Neoplasia 13: 93-103.
45. Feldman GM, Rosenthal LA, Liu X, Hayes MP, Wynshaw-Boris A, et al. (1997) STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. Blood 90: 1768-1776.
46. Turlej RK, Fievez L, Sandersen CF, Dogne S, Kirschvink N, et al. (2001) Enhanced survival of lung granulocytes in an animal model of asthma: evidence for a role of GM-CSF activated STAT5 signalling pathway. Thorax 56: 696-702.
47. Sakamoto K, Schmidt JW, Wagner KU, (2012) Generation of a novel MMTV-tTA transgenic mouse strain for the targeted expression of genes in the embryonic and postnatal mammary gland. PLoS One 7: e43778 10.1371/journal.pone.0043778 [doi];PONE-D-12-16928 [pii].
48. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, et al. (2004) Defining the epithelial stem cell niche in skin. Science 303: 359-363.
49. Creamer BA, Triplett AA, Wagner KU, (2009) Longitudinal analysis of mammogenesis using a novel tetracycline-inducible mouse model and in vivo imaging. Genesis 47: 234-245.
50. Zhang Q, Triplett AA, Harms DW, Lin WC, Creamer BA, et al. (2010) Temporally and spatially controlled expression of transgenes in embryonic and adult tissues. Transgenic Res 19: 499-509.
51. Sakamoto K, Creamer BA, Triplett AA, Wagner KU, (2007) The Janus kinase 2 is required for expression and nuclear accumulation of cyclin D1 in proliferating mammary epithelial cells. Mol Endocrinol 21: 1877-1892.
52. Akashi K, Traver D, Miyamoto T, Weissman IL, (2000) A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404: 193-197 10.1038/35004599 [doi].
53. Kalaitzidis D, Neel BG, (2008) Flow-cytometric phosphoprotein analysis reveals agonist and temporal differences in responses of murine hematopoietic stem/progenitor cells. PLoS One 3: e3776 10.1371/journal.pone.0003776 [doi].
54. Nishida S, Hosen N, Shirakata T, Kanato K, Yanagihara M, et al. (2006) AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1. Blood 107: 3303-3312 2005-04-1656 [pii];10.1182/blood-2005-04-1656 [doi].
55. Zhang Y, Diaz-Flores E, Li G, Wang Z, Kang Z, et al. (2007) Abnormal hematopoiesis in Gab2 mutant mice. Blood 110: 116-124 blood-2006-11-060707 [pii];10.1182/blood-2006-11-060707 [doi].